Clarius Group, LLC Cooper Companies, Inc. Transaction History

Clarius Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$346.15 - $392.09 $1,384 - $1,568	4 Added 0.71%	568 $217,000
Q1 2023 Apr 17, 2023	BUY	$323.56 - $373.36 $182,487 - $210,575	564 New	564 $210,000
Q2 2022 Aug 10, 2022	SELL	$301.4 - $428.42 $169,989 - $241,628	-564 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$373.53 - $434.12 $20,544 - $23,876	55 Added 10.81%	564 $236,000
Q3 2021 Oct 18, 2021	BUY	$396.76 - $455.92 $201,950 - $232,063	509 New	509 $210,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarius Group, LLC with notifications on news.